Thomayant Prueksaritanont

Title: Innovations of Thomayant Prueksaritanont

Introduction

Thomayant Prueksaritanont is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods and compounds that enhance drug efficacy and safety. With a total of 2 patents, his work has the potential to impact various medical conditions.

Latest Patents

One of his latest patents is titled "Screening and selection methods for statin drug combinations." This invention provides a method for screening statins in their open acid form to determine their susceptibility to metabolic glucuronidation. It also includes a method for assessing whether a non-statin pharmaceutical drug, when co-administered with a statin, will inhibit the glucuronidation of the statin, thereby increasing the risk of adverse drug interactions. Another significant patent is related to "αv integrin receptor antagonists." This invention involves novel compounds formed by the metabolic conversion of specific structural formulas. These compounds are useful for inhibiting bone resorption and treating conditions such as osteoporosis, cancer, and diabetic retinopathy.

Career Highlights

Thomayant Prueksaritanont is currently employed at Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to focus on innovative pharmaceutical solutions that address critical health issues.

Collaborations

He has collaborated with notable coworkers, including Byron H. Arison and Donghui Cui, contributing to a dynamic research environment that fosters innovation and development in the pharmaceutical industry.

Conclusion

Thomayant Prueksaritanont's contributions to pharmaceutical innovations demonstrate his commitment to improving drug safety and efficacy. His patents reflect a deep understanding of complex biochemical interactions and a dedication to advancing medical science.